CN3892219
Expired
Amendment A1
Strategic COVID-19 Pharmacology and Drug Development Advice
$1.8M
Contract Value
Contract Details
- Contract ID
- CN3892219
- Status
- active
- Financial Year
- FY26
- Category
- Healthcare Services(UNSPSC: 85110000)
Key Dates
- Publish Date
- 12 Feb 2026
- Signed Date
- 6 July 2022
- Start Date
- 30 June 2022
- End Date
- 30 Dec 2023
- Duration
- 1 year, 6 months
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- AD
- Exemption Reason
- 10.3.e. Additional deliveries by original supplier intended as replacement parts, extensions, or continuation for existing goods or services for compatibility.
Contract History
This contract has been amended 1 time. Currently showing amendment A1.
Original Contract
Published 6 July 2022 · 30 June 2022 to 30 Dec 2023
$650K
Amendment A1
Current
Published 12 Feb 2026 · 30 June 2022 to 30 Dec 2023
$1.8M
+$1.2M
Supplier
CERTARA AUSTRALIA PTY LTD
- ABN
- 28 614 505 592
- Entity Type
- Australian Private Company
- Location
- VIC